Fig. 2 | Scientific Reports

Fig. 2

From: Surgery alone versus neoadjuvant chemoradiotherapy followed by surgery in patients with stage T2N0M0 esophageal cancer

Fig. 2

Survival outcomes of patients with stage T2N0M0 in the unmatched cohort. (A) Cancer-specific survival between surgery alone and neoadjuvant chemoradiotherapy followed by surgery groups. (B) Multivariable proportional hazards regression analysis of cancer-specific survival. (C) Overall survival between surgery alone and neoadjuvant chemoradiotherapy followed by surgery groups. (D) Multivariable proportional hazards regression analysis of overall survival.

Back to article page